{
    "Trade/Device Name(s)": [
        "STA\u00ae - Liatest\u00ae D-Di"
    ],
    "Submitter Information": "Diagnostica Stago",
    "510(k) Number": "K141144",
    "Predicate Device Reference 510(k) Number(s)": [
        "K964728",
        "K040882"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DAP"
    ],
    "Summary Letter Date": "August 1, 2014",
    "Summary Letter Received Date": "August 4, 2014",
    "Submission Date": "April 30, 2014",
    "Regulation Number(s)": [
        "21 CFR 864.7320"
    ],
    "Regulation Name(s)": [
        "Fibrinogen/fibrin degradation products assay"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "D-dimer"
    ],
    "Specimen Type(s)": [
        "Venous plasma"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "STA-R",
        "STA Compact",
        "STA Satellite"
    ],
    "Method(s)/Technology(ies)": [
        "Immuno-turbidimetric assay"
    ],
    "Methodologies": [
        "Immuno-turbidimetric measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for STA\u00ae - Liatest\u00ae D-Di immuno-turbidimetric assay for quantitative determination of D-dimer in plasma to exclude pulmonary embolism and aid diagnosis of deep vein thrombosis",
    "Indications for Use Summary": "Used with STA analyzers by laboratory professionals for quantitative determination of D-dimer in plasma in conjunction with pretest probability assessment to exclude pulmonary embolism and aid diagnosis of deep venous thrombosis in outpatients suspected of PE or DVT",
    "fda_folder": "Hematology"
}